Beyond the Business Pitch at JP Morgan: Key Issues for Emerging Companies and Investors in 2022

Finding the right investor who shares your passion for the mission and the sense of urgency to meet the objectives is key. JP Morgan and Biotech Showcase are bringing industry leaders together again. This authoritative panel will explore and discuss how to make the most of your virtual (and in person) time at JP Morgan & BTS, getting through to the investors, and key issues to consider going into 2022.

Please click here to listen to the recording.


  • Kristin Connarn, Partner, Hogan Lovells
  • Andrew Strong, Partner, Hogan Lovells
  • David de Graaf, PhD, Abcuro, Inc.
  • Kyp Sirinakis, Managing Partner, Epidarex Capital
  • Clifford Stocks, CEO, OncoResponse Inc

Back To Listing